[1] |
McCarthy CP, Murphy S, Venkateswaran RV, et al. Left ventricular thrombus: contemporary etiologies, treatment strategies, and outcomes[J]. J Am Coll Cardiol, 2019, 73(15):2007-2009.
|
[2] |
Asinger RW, Mikell FL, Elsperger J, et al. Incidence of left-ventricular thrombosis after acute transmural myocardial infarction. Serial evaluation by two-dimensional echocardiography[J]. N Engl J Med, 1981, 305(6):297-302.
|
[3] |
Domenicucci S, Chiarella F, Bellotti P, et al. Early appearance of left ventricular thrombi after anterior myocardial infarction: a marker of higher in-hospital mortality in patients not treated with antithrombotic drugs[J]. Eur Heart J, 1990, 11(1):51-58.
|
[4] |
Mooe T, Teien D, Karp K, et al. Left ventricular thrombosis after anterior myocardial infarction with and without thrombolytic treatment[J]. J Intern Med, 1995, 237(6):563-569.
|
[5] |
Zielinska M, Kaczmarek K, Tylkowski M. Predictors of left ventricular thrombus formation in acute myocardial infarction treated with successful primary angioplasty with stenting[J]. Am J Med Sci, 2008, 335(3):171-176.
|
[6] |
Gianstefani S, Douiri A, Delithanasis I, et al. Incidence and predictors of early left ventricular thrombus after ST-elevation myocardial infarction in the contemporary era of primary percutaneous coronary intervention[J]. Am J Cardiol, 2014, 113(7):1111-1116.
|
[7] |
Mao TF, Bajwa A, Muskula P, et al. Incidence of left ventricular thrombus in patients with acute ST-segment elevation myocardial infarction treated with percutaneous coronary intervention[J]. Am J Cardiol, 2018, 121(1):27-31.
|
[8] |
Habash F, Vallurupalli S. Challenges in management of left ventricular thrombus[J]. Ther Adv Cardiovasc Dis, 2017, 11(8):203-213.
|
[9] |
翟玫, 黄丽燕, 王运红, 等. 扩张型心肌病合并心腔内血栓患者的临床特点分析[J]. 中国循环杂志, 2021, 36(6):563-566.
|
[10] |
Lemaître AI, Picard F, Maurin V, et al. Clinical profile and midterm prognosis of left ventricular thrombus in heart failure[J]. ESC Heart Fail, 2021, 8(2):1333-1341.
|
[11] |
Santoro F, Stiermaier T, Tarantino N, et al. Left ventricular thrombi in takotsubo syndrome: incidence, predictors, and management: results from the GEIST (German Italian Stress Cardiomyopathy) registry[J]. J Am Heart Assoc, 2017, 6(12).
|
[12] |
Rowin EJ, Maron BJ, Haas TS, et al. Hypertrophic cardiomyopathy with left ventricular apical aneurysm: implications for risk stratification and management[J]. J Am Coll Cardiol, 2017, 69(7):761-773.
|
[13] |
Girolami A, de Marinis GB, Treleani M, et al. Congenital thrombophilia and intracardiac thrombosis: probably an underdiagnosed event[J]. Cardiol Res, 2013, 4(3):109-115.
|
[14] |
Kaolawanich Y, Boonyasirinant T. Usefulness of apical area index to predict left ventricular thrombus in patients with systolic dysfunction: a novel index from cardiac magnetic resonance[J]. BMC Cardiovasc Disord, 2019, 19(1):15.
|
[15] |
郭影影, 赵肸, 王璐, 等. 急性STEMI患者早期左心室室壁瘤合并左心室血栓的相关因素分析[J]. 中华心血管病杂志, 2021, 49(4):360-367.
|
[16] |
Templin C, Ghadri JR, Diekmann J, et al. Clinical features and outcomes of takotsubo (Stress) cardiomyopathy[J]. N Engl J Med, 2015, 373(10):929-938.
|
[17] |
Ding KJ, Cammann VL, Szawan KA, et al. Intraventricular thrombus formation and embolism in takotsubo syndrome: insights from the international takotsubo registry[J]. Arterioscler Thromb Vasc Biol, 2020, 40(1):279-287.
|
[18] |
Hooks M, Okasha O, Velangi PS, et al. Left ventricular thrombus on cardiovascular magnetic resonance imaging in non-ischaemic cardiomyopathy[J]. Eur Heart J Cardiovasc Imaging, 2021, 22(12):1425-1433.
|
[19] |
Weinsaft JW, Kim RJ, Ross M, et al. Contrast-enhanced anatomic imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus[J]. JACC Cardiovasc Imaging, 2009, 2(8):969-979.
|
[20] |
Roifman I, Connelly KA, Wright GA, et al. Echocardiography vs. cardiac magnetic resonance imaging for the diagnosis of left ventricular thrombus: a systematic review[J]. Can J Cardiol, 2015, 31(6):785-791.
|
[21] |
Weinsaft JW, Kim RJ, Ross M, et al. Contrast-enhanced anatomic imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus[J]. JACC Cardiovasc Imaging, 2009, 2(8):969-979.
|
[22] |
Romero J, Husain SA, Kelesidis I, et al. Detection of left atrial appendage thrombus by cardiac computed tomography in patients with atrial fibrillation: a meta-analysis[J]. Circ Cardiovasc Imaging, 2013, 6(2):185-194.
|
[23] |
Weinsaft JW, Kim J, Medicherla CB, et al. Echocardiographic algorithm for post-myocardial infarction LV thrombus: a gatekeeper for thrombus evaluation by delayed enhancement CMR[J]. JACC Cardiovasc Imaging, 2016, 9(5):505-515.
|
[24] |
Velangi PS, Choo C, Chen KA, et al. Long-term embolic outcomes after detection of left ventricular thrombus by late gadolinium enhancement cardiovascular magnetic resonance imaging: a matched cohort study[J]. Circ Cardiovasc Imaging, 2019, 12(11):e009723.
|
[25] |
Visser CA, Kan G, Meltzer RS, et al. Embolic potential of left ventricular thrombus after myocardial infarction: a two-dimensional echocardiographic study of 119 patients[J]. J Am Coll Cardiol,5(6):1276-1280.
|
[26] |
Lattuca B, Bouziri N, Kerneis M, et al. Antithrombotic therapy for patients with left ventricular mural thrombus[J]. J Am Coll Cardiol, 2020, 75(14):1676-1685.
|
[27] |
O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA Guideline for the management of ST-elevation myocardial infarction: a report of the american college of cardiology foundation/american heart association task force on practice guidelines[J]. Circulation, 2013, 127(4):e362-425.
|
[28] |
Shavadia JS, Youngson E, Bainey KR, et al. Outcomes and prognostic impact of prophylactic oral anticoagulation in anterior ST-segment elevation myocardial infarction patients with left ventricular dysfunction[J]. J Am Heart Assoc, 2017, 6(7).
|
[29] |
Le May MR, Acharya S, Wells GA, et al. Prophylactic warfarin therapy after primary percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction[J]. JACC Cardiovasc Interv, 2015, 8(1 Pt B):155-162.
|
[30] |
Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)[J]. Eur Heart J, 2018, 39(2):119-177.
|
[31] |
Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2014, 45(7):2160-2236.
|
[32] |
Jones DA, Wright P, Alizadeh MA, et al. The use of novel oral anticoagulants compared to vitamin K antagonists (warfarin) in patients with left ventricular thrombus after acute myocardial infarction[J]. Eur Heart J Cardiovasc Pharmacother, 2021, 7(5):398-404.
|
[33] |
Zannad F, Anker SD, Byra WM, et al. Rivaroxaban in patients with heart failure, sinus rhythm, and coronary disease[J]. N Engl J Med, 2018, 379(14):1332-1342.
|
[34] |
Camilli M, Lombardi M, Del Buono MG, et al. Direct oral anticoagulants vs. vitamin K antagonists for the treatment of left ventricular thrombosis: a systematic review of the literature and meta-analysis[J]. Eur Heart J Cardiovasc Pharmacother, 2021, 7(3):e21-e25.
|
[35] |
Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation[J]. Eur Heart J, 2021, 42(14):1289-1367.
|
[36] |
Cannon CP, Bhatt DL, Oldgren J, et al. Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation[J]. N Engl J Med, 2017, 377(16):1513-1524.
|
[37] |
De Luca L, Putini RL, Natale E, et al. One-year clinical outcome of patients with left ventricular thrombus after acute myocardial infarction discharged on triple or dual antithrombotic therapy[J]. J Thromb Thrombolysis, 2022, 53(2):410-416.
|